AutoICD API

87405-7

Laboratory

Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

Definition

This term was created for, but not limited in use to, the submitter's Theradiag Lisa-Tracker Certolizumab and anti-Certolizumab test kits.

LOINC 6-Axis Classification

Component

Certolizumab Ab

Property

ACnc

Time Aspect

Pt

System

Ser/Plas

Scale Type

Qn

Method Type

IA

Details

Class

DRUG/TOX

Order/Observation

Both

Short Name

Certolizumab Ab SerPl IA-aCnc

Display Name

Certolizumab Ab IA Qn

Related Names

ABSAbyAntbyAntiAntibodiesAntibodyArbitrary concentrationAutoantibodiesAutoantibodyCimzia®DRUG/TOXICOLOGYDrugsEIAELFAELISAEnzyme immunoassayIAAMEIAPlPlasmaPlsmPoint in timeQNTQuanQuantQuantitativeRandomSerPSerPlSerPlasSerumSerum or plasmaSRSUDS

Frequently Asked Questions

What is LOINC code 87405-7?

LOINC code 87405-7 identifies "Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay". This term was created for, but not limited in use to, the submitter's Theradiag Lisa-Tracker Certolizumab and anti-Certolizumab test kits.

What does 87405-7 measure?

This code measures Certolizumab Ab in Ser/Plas. It belongs to the DRUG/TOX class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.